<p>Healthcare organisations rely on their financial stakeholders for capital to invest in state-of-the-art buildings, equipment, innovation and the delivery of healthcare services. Nevertheless, relations between healthcare organisations and their financial stakeholders have not been well studied. Here, we studied the relations between Dutch healthcare organisations and two of their main financial stakeholders (banks and health insurers) against the backdrop of system reforms and the financial crisis. We conducted a survey of healthcare executives to evaluate their relations with banks and health insurers in terms of power, legitimacy and urgency. These three attributes are based on the salience model of Mitchel, Agle and Wood (1997). We further tested for differences in power, legitimacy and urgency across organisational sector and size. The results showed that healthcare organisations value banks as legitimate stakeholders with a well-demarcated influence and a clear-cut function. The relationship with health insurers is more complex. Healthcare organisations experience considerable influence from health insurers but question the legitimacy of their claims. Since health insurers play a crucial role in the Dutch healthcare system, these findings question the workability of the relationship between healthcare organisations and health insurers and the position of health insurers in the overall healthcare sector. Our results are relevant to countries with public-private health systems and contribute to the development of the salience model by showing the individual value of stakeholder attributes and the relevance of context.</p>

doi.org/10.1016/j.healthpol.2021.05.002, hdl.handle.net/1765/135988
Physics and Imaging in Radiation Oncology
Erasmus MC: University Medical Center Rotterdam

Jenny Bertholet, Marianne C. Aznar, Cristina Garibaldi, David Thwaites, Eduard Gershkevitsh, Daniela Thorwarth, … Catharine H. Clark. (2021). Professional practice changes in radiotherapy physics during the COVID-19 pandemic. Physics and Imaging in Radiation Oncology, 19, 25–32. doi:10.1016/j.phro.2021.06.002